日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

个性化抗癌疫苗辅助溶瘤病毒治疗

D G Roy, K Geoffroy, M Marguerie, S T Khan, N T Martin, J Kmiecik, D Bobbala, A S Aitken, C T de Souza, K B Stephenson, B D Lichty, R C Auer, D F Stojdl, J C Bell, M-C Bourgeois-Daigneault1

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development

免疫调节基因的删除是溶瘤痘苗病毒开发的一种新方法

Tiffany Y Ho ,David Mealiea ,Lili Okamoto ,David F Stojdl ,J Andrea McCart

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

I型干扰素阻断可解除免疫疗法诱导的抗肿瘤免疫和自身免疫毒性之间的联系

Scott R Walsh ,Donald Bastin ,Lan Chen ,Andrew Nguyen ,Christopher J Storbeck ,Charles Lefebvre ,David Stojdl ,Jonathan L Bramson ,John C Bell ,Yonghong Wan

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

表征溶瘤马拉巴病毒感染期间的细胞反应

Golnoush Hassanzadeh, Thet Naing, Tyson Graber, Seyed Mehdi Jafarnejad, David F Stojdl, Tommy Alain, Martin Holcik

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

利用溶瘤病毒疗法改变前列腺肿瘤微环境

Matthew J Atherton, Kyle B Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K Nikota, Hwan Hee Son, Anna Jirovec, Charles Lefebvre, Anna Dvorkin-Gheva, Ali A Ashkar, Yonghong Wan, David F Stojdl, Eric C Belanger, Rodney H Breau, John C Bell, Fred Saad, Sheila K Singh, Jean-Simone Diallo, Brian D

Development and applications of oncolytic Maraba virus vaccines

溶瘤性马拉巴病毒疫苗的研发与应用

Pol, Jonathan G; Atherton, Matthew J; Bridle, Byram W; Stephenson, Kyle B; Le Boeuf, Fabrice; Hummel, Jeff L; Martin, Chantal G; Pomoransky, Julia; Breitbach, Caroline J; Diallo, Jean-Simon; Stojdl, David F; Bell, John C; Wan, Yonghong; Lichty, Brian D

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain

激活外周固有免疫可实现安全有效的脑部溶瘤病毒疗法

Balathasan, Lukxmi; Tang, Vera A; Yadollahi, Beta; Brun, Jan; Labelle, Melanie; Lefebvre, Charles; Swift, Stephanie L; Stojdl, David F

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

溶瘤病毒与 Smac 模拟化合物协同作用,在同基因小鼠模型中诱导横纹肌肉瘤细胞死亡

Christine C Dobson, Thet Naing, Shawn T Beug, Mame D Faye, Janelle Chabot, Martin St-Jean, Danielle E Walker, Eric C LaCasse, David F Stojdl, Robert G Korneluk, Martin Holcik

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

在抗病毒抗体存在的情况下,补体抑制能够将LCMV糖蛋白假型病毒递送至肿瘤部位。

Evgin, Laura; Ilkow, Carolina S; Bourgeois-Daigneault, Marie-Claude; de Souza, Christiano Tanese; Stubbert, Lawton; Huh, Michael S; Jennings, Victoria A; Marguerie, Monique; Acuna, Sergio A; Keller, Brian A; Lefebvre, Charles; Falls, Theresa; Le Boeuf, Fabrice; Auer, Rebecca A; Lambris, John D; McCart, J Andrea; Stojdl, David F; Bell, John C

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

大数据为溶瘤病毒免疫疗法提供新见解

Swift, Stephanie L; Stojdl, David F